The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo
Cold Atmospheric Plasma (CAP) has shown promising results in the treatment of various skin diseases. The therapeutic effect of CAP on localized scleroderma (LS), however, has not yet been evaluated. We investigated the effects of CAP on LS by comparing human normal fibroblasts (hNF), human TGF-β-act...
Main Authors: | Stephanie Arndt, Petra Unger, Anja-Katrin Bosserhoff, Mark Berneburg, Sigrid Karrer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/11/1545 |
Similar Items
-
A critical role of AREG for bleomycin-induced skin fibrosis
by: Mary Yinghua Zhang, et al.
Published: (2021-02-01) -
Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis
by: Fatemeh Vafashoar, et al.
Published: (2021-11-01) -
Localized scleroderma: A rare clinical entity
by: Ranjana Garg, et al.
Published: (2014-01-01) -
17,20S(OH)<sub>2</sub>pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model
by: Monica L. Brown Lobbins, et al.
Published: (2021-08-01) -
Vitamin A Derivative Etretinate Improves Bleomycin-induced Scleroderma
by: Takaharu Ikeda, et al.
Published: (2005-01-01)